|
- 2019
Validation of the Toronto hepatocellular carcinoma risk index for patients with cirrhosis in China: a retrospective cohort studyDOI: 10.1186/s12957-019-1619-3 Keywords: Cirrhosis, Hepatocellular carcinoma (HCC), Toronto hepatocellular carcinoma risk index (THRI), Validation Abstract: The online version of this article (10.1186/s12957-019-1619-3) contains supplementary material, which is available to authorized users
|